0 Items| Favorites
> Last Item Added:
0 Items
Untitled Document
Millitrack<sup>®</sup> Compliance
Millitrack® Compliance for Milli-Q® systems
Unique, fully-embedded water purification system software for
regulatory compliance

Millitrack® Compliance is a unique e-solution designed to enable regulatory compliance for lab water purification system users.

Users benefit from four important key benefits, including audit trail, electronic signature, full system control and account management features.

Activating Millitrack® Compliance enables full Milli-Q® water purification system compliance with record saving, electronic signature and auditing criteria guidelines such as those of FDA Title 21 CFR Part 11, or similar requirements set by other global regulatory organizations.

With its user-friendly GUI (graphical user interface), Millitrack® Compliance allows users to easily access key information about their laboratory water purification systems through a point-to-point computer or direct network connection using TCP/IP Ethernet protocol.

Users also have the flexibility of being able to monitor water purification system operations at any time through a web browser.

Request more information

Millitrack Compliance Brochure - Download for instant access to specifications and more!
Watch the Instructional Video Now
 
Compliance with Title 21 CFR Part 11 guidelines
Unique, fully-embedded water purification system software for
regulatory compliance

Millitrack® Compliance has been designed specifically for the pharmaceutical, biotech and contract labs that follow GxP regulations (GLP, GCP, or cGMP – U.S. Food and Drug
Administration [FDA] regulations), and which are required to conform to FDA guidelines.
   
   
21 CFR Part 11Activation of the software will enable full Milli-Q® water purification system compliance with record saving, electronic signature and auditing criteria guidelines such as those of FDA Title 21 CFR Part 11 or similar requirements set by other global regulatory organizations, including the European Medicines Agency (EMA) andthe Pharmaceuticals and Medical Devices Agency, Japan.
Read more about Title 21 CFR Part 11.